Yahoo Web Search

Search results

1. • 

     Sparrow Pharmaceuticals Announces Cushing’s Syndrome Treatment Results

     Exec Edge via Yahoo Finance· 2 days ago

     By Daniella Parra Sparrow Pharmaceuticals said its HSD-1 inhibitor, clofutriben (SPI-62), normalized...

2. • 

     Meditating with headband that tracks brain activity may improve surgical recovery in patients with ...

     Medical Xpress· 4 days ago

     Patients with Cushing's syndrome who are recovering from surgery and wear a headband that tracks...

3. • 

     Crinetics Unveils 'Stunning' Results In Highly Anticipated Study

     Investor's Business Daily· 4 days ago

     Crinetics unveiled "stunning" results Monday from a study of a drug that tamps down on levels of a...

4. • 

     Hormonal 'Ups and Downs' Are Normal—but These 8 Symptoms May Point to a True Imbalance

     Well and Good· 17 hours ago

     You've likely heard that it's the culprit for a variety of vague health symptoms, or that "balancing...

5. • 

     Crinetics shares maintain price target, Overweight rating on positive trial data By Investing.com

     Investing.com· 3 days ago

     On Tuesday, Piper Sandler maintained its Overweight rating and $97.00 stock price target for...

6. • 

     Science explains why bearded ladies are so common – but history has treated them cruelly

     The Telegraph via Yahoo News· 4 days ago

     ‘You should be women,” says a terrified Banquo when he and Macbeth meet the witches conjuring spells...

7. • 

     Corcept Therapeutics director Swisher sells $66.5k in stock By Investing.com

     Investing.com· 1 day ago

     Corcept Therapeutics Inc. (NASDAQ:CORT) director Daniel N. Swisher Jr. has recently sold shares of...

8. • 

     Corcept (CORT) Up 24.5% Since Last Earnings Report: Can It Continue?

     Zacks via Yahoo Finance· 7 days ago

     Revenues increased 39% year over year to $146.8 million. The figure beat the Zacks Consensus...

9. • 

     Recordati growth driven by Endocrinology/Oncology, shares PT raised at Deutsche By Investing.com

     Investing.com· 4 days ago

     On Monday, Deutsche Bank adjusted its outlook on Recordati SpA (REC:IM) (OTC: RCDTF), raising the...

10. • 

      Corcept shares target raised on positive trial data, holds Buy rating By Investing.com

      Investing.com· 3 days ago

      Tuesday, Truist Securities has increased its price target for Corcept Therapeutics (NASDAQ:CORT) to...